Skip to content

Anterior Cruciate Ligament Pain Study

Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02604550
Enrollment
115
Registered
2015-11-13
Start date
2015-11-30
Completion date
2016-04-30
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Reconstruction

Brief summary

The objective of this study is to compare the pain control benefit of two different types of nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Detailed description

This trial is a prospective, randomized, surgeon-blinded, two-armed trial to investigate the safety and efficacy of femoral nerve blocks versus adductor canal blocks for participants undergoing outpatient anterior cruciate ligament (ACL) reconstruction surgery. The objective of this study is to compare the pain control benefit of two different types of nerve blocks. Ropivacaine, which is FDA-approved for use in both femoral nerve blocks as well as adductor canal blocks, will be utilized. The study will be comparing the efficacy between FDA approved treatments.

Interventions

Ropivacaine 0.5% will be administered to the femoral nerve or adductor canal.

DRUGPercocet 7.5/325

Percocet 7.5/325 will taken as needed up to every four hours.

DRUGNaprosyn 500 mg

Naprosyn 500 mg will be taken twice daily.

Sponsors

Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing scheduled anterior cruciate ligament (ACL) surgery at the Emory Orthopaedic and Spine Center * Patients willing and able to provide written informed consent * Parents willing and able to provide written informed consent for minors

Exclusion criteria

* Patients who are pregnant or lactating * Patients with liver dysfunction or renal failure * Patients with a known allergy to ropivacaine * Patients with a local infection * Patients who take chronic pain medications * Patients with an opioid tolerance * Patients with known coagulopathy or bleeding risk. * Patients who are getting neuraxial anesthesia for surgery

Design outcomes

Primary

MeasureTime frameDescription
Pain ScorePost-surgery (day of surgery to 6 days post-surgery)Pain scores range from 0 (no pain at all) to 10 (worst imaginable pain). Pain level was reported at the time of discharge from the surgery recovery room, the evening of the day of surgery, and then three times per day for six days post-surgery. During the six days after surgery, the morning assessment asked about typical knee pain levels overnight, the afternoon assessment asked about knee pain levels since the morning entry, and the evening assessment asked about knee pain levels since the afternoon entry.

Secondary

MeasureTime frameDescription
Total Hours of SleepFirst Postoperative Night (up to 12 hours)The total hours of sleep first postoperative night, between 0 to 12 hours.
Patient-Reported NauseaPost-Surgery (up to 6 days)Total occurrences of patient-reported nausea post-surgery.
Patient-Reported VomitingPost-Surgery (up to 6 days)Total occurrences of patient-reported vomiting post-surgery.
Patient-Reported ConstipationPost-Surgery (up to 6 days)Total occurrences of patient-reported constipation post-surgery.
Number of Percocet Tablets ConsumedPost surgery, Day 0 to Day 6Participants recorded the total number of Percocet 7.5/325 (acetaminophen and oxycodone) tablets they took every day, in order to assess post-surgical use of opioids between the study arms,
Patient-Reported ItchingPost-Surgery (up to 6 days)Total occurrences of patient-reported itching post-surgery.
Time to Straight Less RaisePost-Surgery (up to 6 days)The amount of time (in hours) it takes for participants to have the ability to perform a straight leg raise post-surgery.
Percent of Patients Rating Their Satisfaction as Excellent or Good2 Weeks Post-SurgeryPatient satisfaction will be reported on a scale of excellent, good, satisfactory, or poor, two weeks following surgery.
Patient-Reported SedationPost-Surgery (up to 6 days)Total occurrences of patient-reported feelings of sedation post-surgery.

Countries

United States

Participant flow

Recruitment details

Patients undergoing scheduled anterior cruciate ligament (ACL) surgery at the Emory Orthopaedic and Spine Center in Atlanta, Georgia were prospectively randomized to receive either a femoral nerve block (FNB) or an adductor canal block (ACB). Participants were enrolled between December 2015 and April 2016.

Participants by arm

ArmCount
Femoral Nerve Block
Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.
56
Adductor Canal Block
Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal
59
Total115

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyIncomplete data using paper journal1819
Overall StudyLost to Follow-up76
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicFemoral Nerve BlockAdductor Canal BlockTotal
Age, Categorical
<=18 years
14 Participants17 Participants31 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
42 Participants42 Participants84 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants35 Participants78 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
13 Participants24 Participants37 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Black or African American
15 Participants13 Participants28 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
13 Participants24 Participants37 Participants
Race (NIH/OMB)
White
26 Participants21 Participants47 Participants
Region of Enrollment
United States
56 participants59 participants115 participants
Sex: Female, Male
Female
31 Participants33 Participants64 Participants
Sex: Female, Male
Male
25 Participants26 Participants51 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 560 / 59
other
Total, other adverse events
0 / 560 / 59
serious
Total, serious adverse events
0 / 560 / 59

Outcome results

Primary

Pain Score

Pain scores range from 0 (no pain at all) to 10 (worst imaginable pain). Pain level was reported at the time of discharge from the surgery recovery room, the evening of the day of surgery, and then three times per day for six days post-surgery. During the six days after surgery, the morning assessment asked about typical knee pain levels overnight, the afternoon assessment asked about knee pain levels since the morning entry, and the evening assessment asked about knee pain levels since the afternoon entry.

Time frame: Post-surgery (day of surgery to 6 days post-surgery)

Population: This analysis includes participants who completed the study and used a smartphone application to record pain level for 6 days post-surgery.

ArmMeasureGroupValue (MEAN)Dispersion
Femoral Nerve BlockPain ScoreRecovery room discharge4.1 units on a scaleStandard Deviation 1.8
Femoral Nerve BlockPain ScoreDay of surgery, evening3.9 units on a scaleStandard Deviation 2.2
Femoral Nerve BlockPain ScorePost-surgery Day 1 - Morning5.7 units on a scaleStandard Deviation 2.6
Femoral Nerve BlockPain ScorePost-surgery Day 1 - Afternoon5.1 units on a scaleStandard Deviation 2.3
Femoral Nerve BlockPain ScorePost-surgery Day 1 - Evening5.5 units on a scaleStandard Deviation 2.3
Femoral Nerve BlockPain ScorePost-surgery Day 2 - Morning5.4 units on a scaleStandard Deviation 2.3
Femoral Nerve BlockPain ScorePost-surgery Day 2 - Afternoon4.5 units on a scaleStandard Deviation 1.9
Femoral Nerve BlockPain ScorePost-surgery Day 2 - Evening4.3 units on a scaleStandard Deviation 2
Femoral Nerve BlockPain ScorePost-surgery Day 3 - Morning4.2 units on a scaleStandard Deviation 2
Femoral Nerve BlockPain ScorePost-surgery Day 3 - Afternoon3.8 units on a scaleStandard Deviation 1.9
Femoral Nerve BlockPain ScorePost-surgery Day 3 - Evening4.0 units on a scaleStandard Deviation 2.1
Femoral Nerve BlockPain ScorePost-surgery Day 4 - Morning3.5 units on a scaleStandard Deviation 2.2
Femoral Nerve BlockPain ScorePost-surgery Day 4 - Afternoon3.2 units on a scaleStandard Deviation 2.1
Femoral Nerve BlockPain ScorePost-surgery Day 4 - Evening4.0 units on a scaleStandard Deviation 2.4
Femoral Nerve BlockPain ScorePost-surgery Day 5 - Morning3.7 units on a scaleStandard Deviation 2.2
Femoral Nerve BlockPain ScorePost-surgery Day 5 - Afternoon3.6 units on a scaleStandard Deviation 2.1
Femoral Nerve BlockPain ScorePost-surgery Day 5 - Evening3.4 units on a scaleStandard Deviation 2.3
Femoral Nerve BlockPain ScorePost-surgery Day 6 - Morning3.7 units on a scaleStandard Deviation 2.2
Femoral Nerve BlockPain ScorePost-surgery Day 6 - Afternoon3.2 units on a scaleStandard Deviation 1.6
Femoral Nerve BlockPain ScorePost-surgery Day 6 - Evening2.7 units on a scaleStandard Deviation 1.6
Adductor Canal BlockPain ScorePost-surgery Day 6 - Morning3.1 units on a scaleStandard Deviation 2.2
Adductor Canal BlockPain ScoreRecovery room discharge4.0 units on a scaleStandard Deviation 2.8
Adductor Canal BlockPain ScorePost-surgery Day 3 - Evening3.7 units on a scaleStandard Deviation 2.3
Adductor Canal BlockPain ScoreDay of surgery, evening5.1 units on a scaleStandard Deviation 2.9
Adductor Canal BlockPain ScorePost-surgery Day 5 - Afternoon3.3 units on a scaleStandard Deviation 2.2
Adductor Canal BlockPain ScorePost-surgery Day 1 - Morning5.7 units on a scaleStandard Deviation 2.4
Adductor Canal BlockPain ScorePost-surgery Day 4 - Morning3.0 units on a scaleStandard Deviation 2.2
Adductor Canal BlockPain ScorePost-surgery Day 1 - Afternoon5.0 units on a scaleStandard Deviation 1.8
Adductor Canal BlockPain ScorePost-surgery Day 6 - Evening2.8 units on a scaleStandard Deviation 2.2
Adductor Canal BlockPain ScorePost-surgery Day 1 - Evening6.0 units on a scaleStandard Deviation 2.1
Adductor Canal BlockPain ScorePost-surgery Day 4 - Afternoon2.7 units on a scaleStandard Deviation 2
Adductor Canal BlockPain ScorePost-surgery Day 2 - Morning5.3 units on a scaleStandard Deviation 2.3
Adductor Canal BlockPain ScorePost-surgery Day 5 - Evening3.3 units on a scaleStandard Deviation 2.4
Adductor Canal BlockPain ScorePost-surgery Day 2 - Afternoon4.6 units on a scaleStandard Deviation 1.8
Adductor Canal BlockPain ScorePost-surgery Day 4 - Evening3.3 units on a scaleStandard Deviation 2.4
Adductor Canal BlockPain ScorePost-surgery Day 2 - Evening4.5 units on a scaleStandard Deviation 2.1
Adductor Canal BlockPain ScorePost-surgery Day 6 - Afternoon3.2 units on a scaleStandard Deviation 2
Adductor Canal BlockPain ScorePost-surgery Day 3 - Morning4.0 units on a scaleStandard Deviation 3.1
Adductor Canal BlockPain ScorePost-surgery Day 5 - Morning3.1 units on a scaleStandard Deviation 2.1
Adductor Canal BlockPain ScorePost-surgery Day 3 - Afternoon3.4 units on a scaleStandard Deviation 2.5
Secondary

Number of Percocet Tablets Consumed

Participants recorded the total number of Percocet 7.5/325 (acetaminophen and oxycodone) tablets they took every day, in order to assess post-surgical use of opioids between the study arms,

Time frame: Post surgery, Day 0 to Day 6

Population: This analysis includes participants who completed the study and used a smartphone application to record the number of Percocet tablets taken for 6 days post-surgery.

ArmMeasureGroupValue (MEAN)Dispersion
Femoral Nerve BlockNumber of Percocet Tablets ConsumedPost-surgery Day 23.7 count of tabletsStandard Deviation 2.6
Femoral Nerve BlockNumber of Percocet Tablets ConsumedPost-surgery Day 41.1 count of tabletsStandard Deviation 1.3
Femoral Nerve BlockNumber of Percocet Tablets ConsumedPost-surgery Day 14.6 count of tabletsStandard Deviation 2.5
Femoral Nerve BlockNumber of Percocet Tablets ConsumedPost-surgery Day 50.6 count of tabletsStandard Deviation 1.4
Femoral Nerve BlockNumber of Percocet Tablets ConsumedPost-surgery Day 32.3 count of tabletsStandard Deviation 1.9
Femoral Nerve BlockNumber of Percocet Tablets ConsumedPost-surgery Day 60.3 count of tabletsStandard Deviation 0.7
Femoral Nerve BlockNumber of Percocet Tablets ConsumedDay of surgery (Day 0)2.0 count of tabletsStandard Deviation 1.2
Adductor Canal BlockNumber of Percocet Tablets ConsumedPost-surgery Day 60.4 count of tabletsStandard Deviation 0.7
Adductor Canal BlockNumber of Percocet Tablets ConsumedDay of surgery (Day 0)2.4 count of tabletsStandard Deviation 1.7
Adductor Canal BlockNumber of Percocet Tablets ConsumedPost-surgery Day 14.7 count of tabletsStandard Deviation 2.9
Adductor Canal BlockNumber of Percocet Tablets ConsumedPost-surgery Day 23.6 count of tabletsStandard Deviation 2.6
Adductor Canal BlockNumber of Percocet Tablets ConsumedPost-surgery Day 32.2 count of tabletsStandard Deviation 2.2
Adductor Canal BlockNumber of Percocet Tablets ConsumedPost-surgery Day 41.2 count of tabletsStandard Deviation 2.1
Adductor Canal BlockNumber of Percocet Tablets ConsumedPost-surgery Day 51.4 count of tabletsStandard Deviation 1.5
Secondary

Patient-Reported Constipation

Total occurrences of patient-reported constipation post-surgery.

Time frame: Post-Surgery (up to 6 days)

Population: This analysis includes participants completing the study and who used a smartphone application for 6 days post-operatively to record every time they experienced constipation.

ArmMeasureValue (NUMBER)
Femoral Nerve BlockPatient-Reported Constipation2 occurrence of constipation
Adductor Canal BlockPatient-Reported Constipation1 occurrence of constipation
Secondary

Patient-Reported Itching

Total occurrences of patient-reported itching post-surgery.

Time frame: Post-Surgery (up to 6 days)

Population: This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced itching.

ArmMeasureValue (NUMBER)
Femoral Nerve BlockPatient-Reported Itching2 occurrence of itching
Adductor Canal BlockPatient-Reported Itching1 occurrence of itching
Secondary

Patient-Reported Nausea

Total occurrences of patient-reported nausea post-surgery.

Time frame: Post-Surgery (up to 6 days)

Population: This analysis includes participants completing the study who used a smartphone application for 6 days post-operatively to record every time they experienced nausea.

ArmMeasureValue (NUMBER)
Femoral Nerve BlockPatient-Reported Nausea3 occurrence of nausea
Adductor Canal BlockPatient-Reported Nausea2 occurrence of nausea
Secondary

Patient-Reported Sedation

Total occurrences of patient-reported feelings of sedation post-surgery.

Time frame: Post-Surgery (up to 6 days)

Population: This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced feelings of sedation.

ArmMeasureValue (NUMBER)
Femoral Nerve BlockPatient-Reported Sedation0 occurrence of sedation
Adductor Canal BlockPatient-Reported Sedation0 occurrence of sedation
Secondary

Patient-Reported Vomiting

Total occurrences of patient-reported vomiting post-surgery.

Time frame: Post-Surgery (up to 6 days)

Population: This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced vomiting.

ArmMeasureValue (NUMBER)
Femoral Nerve BlockPatient-Reported Vomiting1 occurrence of vomiting
Adductor Canal BlockPatient-Reported Vomiting1 occurrence of vomiting
Secondary

Percent of Patients Rating Their Satisfaction as Excellent or Good

Patient satisfaction will be reported on a scale of excellent, good, satisfactory, or poor, two weeks following surgery.

Time frame: 2 Weeks Post-Surgery

Population: This analysis includes participants who completed the study and used a smartphone application to record study outcome measures following surgery.

ArmMeasureValue (NUMBER)
Femoral Nerve BlockPercent of Patients Rating Their Satisfaction as Excellent or Good39 percentage of participants
Adductor Canal BlockPercent of Patients Rating Their Satisfaction as Excellent or Good64 percentage of participants
Secondary

Time to Straight Less Raise

The amount of time (in hours) it takes for participants to have the ability to perform a straight leg raise post-surgery.

Time frame: Post-Surgery (up to 6 days)

Population: This analysis includes participants who completed the study and used a smartphone application to record when they were able to perform a straight leg raise following surgery.

ArmMeasureValue (MEAN)Dispersion
Femoral Nerve BlockTime to Straight Less Raise31.7 hoursStandard Deviation 26.1
Adductor Canal BlockTime to Straight Less Raise16.4 hoursStandard Deviation 10.5
Secondary

Total Hours of Sleep

The total hours of sleep first postoperative night, between 0 to 12 hours.

Time frame: First Postoperative Night (up to 12 hours)

Population: This analysis includes participants who completed the study and used a smartphone application to record their number of hours of sleep during the night following their surgery.

ArmMeasureValue (MEAN)Dispersion
Femoral Nerve BlockTotal Hours of Sleep6.3 hoursStandard Deviation 2
Adductor Canal BlockTotal Hours of Sleep5.8 hoursStandard Deviation 1.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026